Richard Pzena Exelixis, Inc. Transaction History

Pzena Investment Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$20.17 - $23.93 $15,228 - $18,067	755 Added 3.98%	19,734 $468,000
Q4 2023 Feb 09, 2024	SELL	$19.25 - $24.13 $58,674 - $73,548	-3,048 Reduced 13.84%	18,979 $455,000
Q3 2023 Nov 09, 2023	BUY	$19.04 - $22.74 $70,657 - $84,388	3,711 Added 20.26%	22,027 $481,000
Q2 2023 Aug 04, 2023	SELL	$18.17 - $20.48 $194,328 - $219,033	-10,695 Reduced 36.87%	18,316 $350,000
Q1 2023 May 12, 2023	SELL	$16.3 - $19.41 $352,666 - $419,954	-21,636 Reduced 42.72%	29,011 $563,000
Q4 2022 Feb 03, 2023	BUY	$14.96 - $17.39 $448,470 - $521,317	29,978 Added 145.04%	50,647 $812,000
Q1 2022 May 06, 2022	BUY	$17.03 - $22.67 $351,993 - $468,566	20,669 New	20,669 $469,000
Q1 2021 May 07, 2021	SELL	$20.53 - $25.22 $582,579 - $715,667	-28,377 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$18.39 - $24.8 $138,973 - $187,413	7,557 Added 36.3%	28,377 $570,000
Q3 2020 Oct 30, 2020	SELL	$20.67 - $26.94 $142,788 - $186,101	-6,908 Reduced 24.91%	20,820 $509,000
Q2 2020 Jul 31, 2020	SELL	$16.46 - $27.42 $137,539 - $229,121	-8,356 Reduced 23.16%	27,728 $658,000
Q1 2020 May 01, 2020	BUY	$14.46 - $21.8 $521,774 - $786,631	36,084 New	36,084 $621,000
Q3 2019 Nov 01, 2019	SELL	$17.68 - $22.65 $261,717 - $335,287	-14,803 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$18.93 - $24.75 $7,893 - $10,320	-417 Reduced 2.74%	14,803 $316,000
Q1 2019 May 03, 2019	BUY	$19.6 - $24.76 $298,312 - $376,847	15,220 New	15,220 $362,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.